We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current GANX market cap is 35.12M. The company's latest EPS is USD -1.3626 and P/E is -2.00.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 95k | 0 | 0 | 55k | 0 |
| Operating Income | -5.18M | -4.75M | -4.56M | -5.23M | -7.73M |
| Net Income | -5.09M | -4.56M | -4.68M | -5.14M | -7.69M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 41k | 29k | 196k | 140k |
| Operating Income | -2.1M | -3.48M | -13.8M | -17.78M |
| Net Income | -2.19M | -3.58M | -13.86M | -17.59M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 31.89M | 28.33M | 24.1M | 21.32M | 18.26M |
| Total Liabilities | 4.87M | 5.66M | 5.22M | 6.18M | 7.17M |
| Total Equity | 27.02M | 22.66M | 18.88M | 15.14M | 11.09M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 660k | 9.6M | 38.99M | 24.1M |
| Total Liabilities | 1.11M | 3.4M | 4.17M | 5.22M |
| Total Equity | -450k | 6.2M | 34.82M | 18.88M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -7.5M | -10.79M | -14.69M | -4.22M | -9.24M |
| Investing | -14.9M | -14.91M | -14.78M | 2.11M | 5.15M |
| Financing | -37k | -57k | -79k | 748k | 2.95M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.87M | -3.24M | -12.37M | -14.69M |
| Investing | -14k | -21k | -94k | -14.78M |
| Financing | 1.75M | 10.49M | 41.77M | -79k |
| Market Cap | 35.12M |
| Price to Earnings Ratio | -2.00 |
| Price to Sales Ratio | 251.85 |
| Price to Cash Ratio | 4.82 |
| Price to Book Ratio | 1.86 |
| Dividend Yield | - |
| Shares Outstanding | 12.91M |
| Average Volume (1 week) | 75.37k |
| Average Volume (1 Month) | 89.38k |
| 52 Week Change | -16.31% |
| 52 Week High | 6.19 |
| 52 Week Low | 2.00 |
| Spread (Intraday) | 0.45 (14.38%) |
| Company Name | Gain Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.gaintherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
